Evidence map›Paper›PMID 28787640›Full record

ReviewArchives of oral biology2017

A review of in-vitro fibrocartilage tissue engineered therapies with a focus on the temporomandibular joint.

Jesse Lowe, Alejandro J Almarza

Abstract readReview
In one paragraph

Review in Archives of oral biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. 3D Bioprinted Highly Elastic Hybrid Constructs for Advanced Fibrocartilaginous Tissue Regeneration.Chemistry of materials : a publication of the American Chemical Society · 2020
    Article
  11. Article
  12. Tissue Engineering for the Temporomandibular Joint.Advanced healthcare materials · 2019
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jesse LoweDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15260, United States; Center for Craniofacial Regeneration, University of Pittsburgh, Pittsburgh, PA 15260, United States. Electronic address: lowej777@gmail.com.
Alejandro J AlmarzaDepartment of Oral Biology, University of Pittsburgh, Pittsburgh, PA 15260, United States; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15260, United States; Center for Craniofacial Regeneration, University of Pittsburgh, Pittsburgh, PA 15260, United States; McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15260, United States. Electronic address: aja19@pitt.edu.

Funding

Training in Biomechanics in Regenerative MedicineT32EB003392 · NIBIB · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WOO, SAVIO L-Y. · 2005 to 2020
$4.0M
A Regenerative Medicine Approach for TMJ Meniscus RestorationR01DE022055 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ALMARZA, ALEJANDRO JOSE, BADYLAK, STEPHEN F. · 2012 to 2015
$2.5M
ECM Scaffold Remodels Into a TMJ Disc AnalogueF31DE025810 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LOWE, JESSE · 2016 to 2016
$38k
NIBIB NIH HHS T32 EB003392NIDCR NIH HHS F31 DE025810NIDCR NIH HHS R01 DE022055
6 · The paper itself

Abstract

The inability of fibrocartilage, specifically the temporomandibular joint (TMJ) disc, to regenerate and remodel following injury presents a unique problem for clinicians. Tissue engineering then offers a potential regenerative therapy. In vitro testing provides a valuable screening tool for potential tissue engineered solutions. The conclusions drawn for TMJ in vitro research were compared against state of the art fibrocartilage studies in the knee meniscus, and annulus fibrosus of the intervertebral disc (IVD). For TMJ disc regeneration, in vitro tissue engineered approaches, focused on cellular therapies with fibrochondrocytes, have displayed an inability to produce enough collagen, as well as an inability to recapitulate native mechanical properties. Biomaterial approaches have recapitulated the native properties of the TMJ disc, but their in vivo efficacy has yet to be determined. By comparison, the knee meniscus field is the most progressive in the use of stem cells as a cell source. The knee meniscus field has moved away from measuring mechanical properties, and are instead more focused on biochemistry and gene expression. IVD studies mainly use electrospun scaffolds, and have produced the best success in mechanical properties. The TMJ field, in comparison to knee meniscus and IVD, needs to employ stem cell therapies, new biomaterials and manufacturing techniques, and cutting edge molecular assays, in future in vitro approaches to screen for viable technologies to move to in vivo studies.

Indexed as

Biomechanical PhenomenaFibrocartilageIntervertebral DiscIn Vitro TechniquesMenisci, TibialTemporomandibular Joint DiscTemporomandibular Joint DisordersTissue EngineeringTissue ScaffoldsFibrocartilageIn vitroTemporomandibular jointTissue engineering

Identifiers

PMID28787640
PMCPMC5614869

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.